Funding · Company
Rivus Pharmaceuticals, Inc.
Charlottesville, VABiotech & Pharma
Rivus Pharmaceuticals, Inc. of Charlottesville, VA has disclosed $223M across 4 Form D offerings filed with the SEC between Oct 4, 2021 and Jan 16, 2025.
$223M
Total disclosed
4
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$35M
Form D · Oct 4, 2021 ↗
Q4 2021
· target $35M
Filing details
HeadquartersCharlottesville, VAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2019SEC CIK0001773293Offerings on file4
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →